Dispensing Dexcom G7 CGM – Pharmacist Info

THE CONTINUOUS GLUCOSE MONITORING (CGM)
SYSTEM TRANSFORMING DIABETES MANAGEMENT

With Dexcom G7, there is no separate transmitter needed. Each box contains 1 sensor that will last for 10 days, so each monthly prescription should include 3 boxes. If patients opt to use a compatible smart device, only dispense the sensor boxes. If patients do not have a smart device, the Dexcom G7 receiver will be required to access their data.

The Dexcom G7 sensor and receiver are available through major retailers, including Cardinal Health, McKesson, AmerisourceBergen, Dakota Drug, and Smith Drug.

DOWNLOAD THE PHARMACY TOOLKIT
FOR MORE INFORMATION

DOWNLOAD NOW

dexcom g7

dexcom g7 receiver

PRODUCT COMPONENTS	DEXCOM G7 SENSOR	DEXCOM G7 RECEIVER^†
PRODUCT NRC	08627-0077-01	08627-0078-01
FILL	3 boxes (1 sensor per box)	1
REFILLS	30 days	1 year

*To view a list of compatible devices, visit dexcom.com/compatibility. ^†Receiver required for Medicare beneficiaries.

DEXCOM G7 IS BUILT FOR POWERFULLY

SIMPLE, CONFIDENT DIABETES MANAGEMENT

Dexcom G7 is indicated for use with children ages 2 and up,

and it can be used with no limitations during pregnancy.

the most accurate CGM¹

INDUSTRY-LEADING CGM THAT IMPROVES OUTCOMES^2-7

>1% A1C reduction^*,1,7
More time in range^2-6
Lower hyper- and hypoglycemia^2-6

Dexcom G7 Continuous Glucose Monitor for type-1 and type-2 diabetes patients

Smart device sold separately.*

the simple CGM

FOR EFFORTLESS DIABETES MANAGEMENT THAT LEADS TO BETTER ADHERENCE^†,7

the most covered CGM brand¹⁰

AFFORDABLE CARE FOR PATIENTS WITH DIABETES TYPE 1 OR 2, DURING PREGNANCY, OR THOSE ON MEDICARE^‡,8

3x graphic

Pay $0 than FreeStyle Libre patients¹⁰

only 1 prescription needed

Your patients can start quickly with the Simple Start Program at the pharmacy

IF YOUR PATIENT NEEDS HELP WITH COVERAGE,
THE DEXCOM SAVINGS CENTER CAN HELP

LEARN MORE

*Results obtained in a real-world study after 12 weeks of use (N=248). ^†Based on 30 days of use. ^‡Must meet eligibility requirements. Under Medicare’s DME fee schedule, reimbursement for CGMs, using CPT codes K0554 and K0553, is the same, regardless of CGM brand. Regulation at 42 CFR 410.152(b), stipulates that coinsurance for items of durable medical equipment is 20% of the allowed amount.

the all-in-one app experience

Dexcom G7 is the latest in CGM technology, offering an all-in-one app experience made to help empower patients to act before a potentially dangerous hypo- or hyperglycemia event.

Features a simplified design and real-time and retrospective insights

Patients can view their glucose readings directly on a compatible smart device or a Dexcom G7 receiver

No scanning and no fingersticks required

Flexible alerts including a hyperglycemia alert and a new Urgent Low Soon alert

Patients can use the separate Follow app* to share glucose information with up to 10 followers

*Followers must have compatible smart devices to use the Dexcom Follow app.

getting patients started with Dexcom G7 is easy

Applying Dexcom G7 is simple

Select sensor site
Insert the sensor using the applicator
Pair the receiver or compatible smart device
Dexcom G7 features a fast 30-minute warmup once applied to the body
Keep smart device or receiver nearby during warmup

WATCH THE FULL VIDEO

pharmacy toolkit

Dexcom G7 pharmacy toolkit

The toolkit is designed to help answer any questions you or your patients may have about Dexcom G7.

DOWNLOAD THE PHARMACY TOOLKIT FOR MORE INFORMATION

DOWNLOAD NOW

are your patients connected to a pump?

We recommend new users on automated insulin delivery (AID) systems to explore the benefits of Dexcom G6 and for existing users on AID systems to stay on Dexcom G6 until Dexcom G7 is compatible with your pump.

EXPLORE DEXCOM G6

1 Dexcom, data on file, 2022. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 7 Seagrove Partners Patient Perspectives, 2022. 8 Dexcom G7 CGM System User Guide. 9 FreeStyle Libre 3 Quick Start Guide. Abbott Diabetes Care Inc.; 2022. 10 Managed Markets Insights & Technology, LLC. MMIT Analytics, June 2022.

The circular shape of the sensor housing, FreeStyle Libre, and related brand marks are marks of Abbott.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider's NPI

Please provide the facility address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

dispensing Dexcom G7 CGM: